Previous Close | 201.48 |
Open | 202.25 |
Bid | 0.00 x 1200 |
Ask | 0.00 x 800 |
Day's Range | 200.67 - 203.89 |
52 Week Range | 179.59 - 234.09 |
Volume | |
Avg. Volume | 744,403 |
Market Cap | 17.083B |
Beta (5Y Monthly) | 1.00 |
PE Ratio (TTM) | 46.90 |
EPS (TTM) | 4.33 |
Earnings Date | Apr 25, 2024 |
Forward Dividend & Yield | 2.88 (1.42%) |
Ex-Dividend Date | May 28, 2024 |
1y Target Est | 246.13 |
Get a deeper insight into the potential performance of Labcorp (LH) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.